Massy, Ziad A

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet

Lipoproteins and Cardiovascular HealthChronic Kidney Disease and Diabetes

Cited by 2,479

Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis

Writing Group for the CKD Prognosis Consortium, Appel, L. J., Grams, M., Woodward, M., Harris, K., Arima, H., Chalmers, J., Yatsuya, H., Tamakoshi, K., Li, Y., et al. (2023) · JAMA

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 396

Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target

Ramezani, A., Massy, Z. A., Meijers, B., Evenepoel, P., Vanholder, R., & Raj, D. S. (2016) · American Journal of Kidney Diseases

Gut microbiota and healthDialysis and Renal Disease Management

Cited by 394

Uremia Accelerates both Atherosclerosis and Arterial Calcification in Apolipoprotein E Knockout Mice

Massy, Z. A., Ivanovski, O., Nguyen-Khoa, T., Angulo, J., Szumilak, D., Mothu, N., Phan, O., Daudon, M., Lacour, B., Dru[Combining Diaeresis]eke, T. B., et al. (2005) · Journal of the American Society of Nephrology

Atherosclerosis and Cardiovascular DiseasesParathyroid Disorders and Treatments

Cited by 203

The double challenge of resistant hypertension and chronic kidney disease

Rossignol, P., Massy, Z. A., Azizi, M., Bakris, G., Ritz, E., Covic, A., Goldsmith, D., Heine, G. H., Jager, K. J., Kanbay, M., et al. (2015) · The Lancet

Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes

Cited by 194

Anemia and iron deficiency among chronic kidney disease Stages 3–5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated

Wong, M. M. Y., Tu, C., Li, Y., Perlman, R. L., Pecoits-Filho, R., Lopes, A. A., Narita, I., Reichel, H., Port, F. K., Sukul, N., et al. (2020) · Clinical Kidney Journal

Erythropoietin and Anemia TreatmentIron Metabolism and Disorders

Cited by 140

Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Profiles

Parati, G., Ochoa, J. E., Bilo, G., Agarwal, R., Covic, A., Dekker, F. W., Fliser, D., Heine, G. H., Jager, K. J., Gargani, L., et al. (2016) · Hypertension

Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes

Cited by 112

Smoking and adverse outcomes in patients with CKD: The Study of Heart and Renal Protection (SHARP)

Staplin, N., Haynes, R., Herrington, W. G., Reith, C., Cass, A., Fellström, B., Jiang, L., Kasiske, B. L., Krane, V., Levin, A., et al. (2016) · American Journal of Kidney Diseases

Smoking Behavior and CessationChronic Kidney Disease and Diabetes

Cited by 86

Hypertension in Chronic Kidney Disease Part 1: Out-of-Office Blood Pressure Monitoring: Methods, Thresholds, and Patterns

Parati, G., Ochoa, J. E., Bilo, G., Agarwal, R., Covic, A., Dekker, F. W., Fliser, D., Heine, G. H., Jager, K. J., Gargani, L., et al. (2016) · Hypertension

Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes

Cited by 76

The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD)

Goldsmith, D. J. A., Massy, Z. A., & Brandenburg, V. (2014) · Seminars in Nephrology

Parathyroid Disorders and TreatmentsVitamin D Research Studies

Cited by 21